Halozyme Therapeutics shares owned by Segall Bryant & Hamill
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Segall Bryant & Hamill
from 13F filings
Historical chart of Segall Bryant & Hamill investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Segall Bryant & Hamill consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Segall Bryant & Hamill
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $9.0M | 243k | 36.96 |
| 2023-09-30 | $8.3M | 218k | 38.20 |
| 2023-06-30 | $9.5M | 263k | 36.07 |
| 2023-03-31 | $7.1M | 186k | 38.19 |
| 2022-12-31 | $11M | 187k | 56.89 |
| 2022-09-30 | $7.5M | 191k | 39.53 |
| 2017-12-31 | $271k | 13k | 20.22 |
| 2017-09-30 | $233k | 13k | 17.39 |
| 2017-06-30 | $172k | 13k | 12.84 |
| 2017-03-31 | $174k | 13k | 12.99 |
| 2016-12-31 | $330k | 33k | 9.88 |
| 2014-03-31 | $140k | 11k | 12.73 |